RNS Number : 7802Y
Circassia Pharmaceuticals Plc
19 May 2016
For immediate release
Circassia Pharmaceuticals plc
Appointment of Broker
19 May 2016
Circassia Pharmaceuticals plc (LSE: CIR) announces that it has appointed Numis Securities Limited as joint broker to the Company, alongside JP Morgan Cazenove, with immediate effect.
- Ends -
Enquiries
|
Circassia Steve Harris, Chief Executive Officer Julien Cotta, Chief Financial Officer Rob Budge, Corporate Communications |
Tel: +44 (0)1865 405 560 |
|
Numis Securities Clare Terlouw / Michael Meade |
Tel: +44 (0) 20 7260 1000 |
|
JP Morgan Cazenove James Mitford / James Deal |
Tel: +44 (0) 20 7742 4000 |
|
FTI Consulting Ben Atwell / Simon Conway / Mo Noonan |
Tel: +44 (0) 20 3727 1000 |
This information is provided by RNS
The company news service from the London Stock Exchange